Potential role of microRNAs as biomarkers in human glioblastoma: a mini systematic review from 2015 to 2020
Author:
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-021-06423-9.pdf
Reference58 articles.
1. Scheithauer BW (2009) Development of the WHO classification of tumors of the central nervous system: a historical perspective. Brain Pathol 19(4):551–564. https://doi.org/10.1111/j.1750-3639.2008.00192.x
2. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. https://doi.org/10.1007/s00401-007-0243-4
3. Ferreira WAS, do Pinheiro DR, da Costa Junior CA et al (2016) An update on the epigenetics of glioblastomas. Epigenomics 8(9):1289–1305. https://doi.org/10.2217/epi-2016-0040
4. Omuro A (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310(17):1842–1850. https://doi.org/10.1001/jama.2013.280319
5. Thakkar JP, Dolecek TA, Horbinski C et al (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23(10):1985–1996. https://doi.org/10.1158/1055-9965.EPI-14-0275
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges;International Journal of Molecular Sciences;2024-07-21
2. Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis;Cells;2024-02-02
3. Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities;Pathology - Research and Practice;2024-01
4. NCDN is a Potential Biomarker and Therapeutic Target for Glioblastoma;Journal of Cancer;2024
5. The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives;Current Research in Pharmacology and Drug Discovery;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3